Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
JAMA|July 17, 2014
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trialJacques-Eric Gottenberg, Philippe Ravaud, Xavier Puéchal, et al.
The Lancet. Rheumatology|March 4, 2024
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohortsYann Nguyen, Gaëtane Nocturne, Julien Henry, et al.
Blood|May 24, 2015
Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosisStéphane Barete, Olivier Lortholary, Gandhi Damaj, et al.
Plos One|May 30, 2013
Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohortJacques-Eric Gottenberg, Raphaèle Seror, Corinne Miceli-Richard, et al.
The Journal of Allergy and Clinical Immunology|September 7, 2023
Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variantsCoralie Bloch, Jean Philippe Jais, Marine Gil, et al.
Joint Bone Spine|February 22, 2021
Epidemiology of cutaneous involvement in Sjögren syndrome: Data from three French pSS populations (TEARS, ASSESS, diapSS)Camille Villon, Laure Orgeolet, Anne-Marie Roguedas, et al.
Seminars in Arthritis and Rheumatism|July 20, 2014
Association of mastocytosis with inflammatory joint diseases: a series of 31 patientsBrigitte Bader-Meunier, Cristina Bulai Livideanu, Claire Larroche, et al.
Medicine|July 26, 2018
Characteristics, outcome and treatments with cranial pachymeningitis: A multicenter French retrospective study of 60 patientsArsene Mekinian, Lucas Maisonobe, Latifatou Boukari, et al.
Plos One|September 15, 2015
Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?Valérie Devauchelle-Pensec, Jacques-Eric Gottenberg, Sandrine Jousse-Joulin, et al.
Autoimmunity Reviews|May 10, 2017
Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patientsPierre-Edouard Gavand, Ilaria Serio, Laurent Arnaud, et al.
Pageof 5